Patients with recurrent prostate, breast, or ovarian cancer exhibit higher levels of IL-8 in serum or peripheral blood leukocytes [138, 144, 145] and in cancer tissues [34]. This evidence concerns the gene CXCL8 and ovarian carcinoma.